Skip to content
Screener

Medtronic MDT Q4 2025 Annual earnings

Reported May 21, 2025 · Before market open

Revenue$8.9BBeat by $108.4M
EPS$1.62Beat by $0.04
Revenue estimate$8.8B
EPS estimate$1.58

Next report

Sep 1, 2026 (In 4 days)
Revenue estimate$9.5B
EPS estimate$1.39

Financials

Q4 2025

Income statement

See full
Revenue$8.9B+3.9%
Gross profit$5.8B+4.2%
Operating income$1.4B+36.4%
Net income$1.1B+61.5%
EPS (diluted)$0.82+67.3%

Balance sheet

See full
Cash & equivalents$2.2B+72.7%
Total debt$29.7B+13.7%
Total equity$48.0B-4.4%
Total assets$91.7B+1.9%

Cash flow

See full
Operating cash flow$2.5B-9.0%
CapEx$459.0M+7.7%
Free cash flow$2.1B-12.0%

Valuation & ratios

Valuation

as of 04/25/25
See full
Market cap$108.12B+1.3%
Enterprise value$135.58B+3.1%
P/E23.2×-5.8×
P/S3.2×-0.1×

Profitability

See full
Gross margin65.3%0.0pp
Operating margin17.8%+1.9pp
Net margin13.9%+2.5pp
FCF margin15.5%-0.6pp

Returns & leverage

See full
Return on equity9.5%+2.3pp
Debt / equity0.6×+0.1×
Current ratio1.8×-0.2×

Segments

By segment

See full
Cardiovascular$3.3B+6.6%
Neuroscience$2.6B+2.9%
Medical Surgical$2.2B+0.6%
Diabetes$728.0M+10.5%
Other operating segment$31.0M-45.6%

FAQ

When did Medtronic report Q4 2025 earnings?
Medtronic (MDT) reported Q4 2025 earnings on May 21, 2025 before market open.
What were Medtronic's Q4 2025 revenue and EPS?
Medtronic reported revenue of $8.9B and eps of $1.62 for Q4 2025.
Did Medtronic beat estimates in Q4 2025?
Revenue beat the consensus estimate of $8.8B by $108.4M. EPS beat the consensus estimate of $1.58 by $0.04.
How did Medtronic's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.9% from $8.6B a year earlier and eps grew 11.0% from $1.46.
Where can I find Medtronic's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001613103-25-000078) and the 10-K periodic report (0001613103-25-000091) directly on SEC EDGAR. The filing index links above go to sec.gov.